Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Note 14 - Stock-based Compensation - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Stock based compensation	$ 1,858	$ 2,546
Selling and Marketing Expense [Member]
Stock based compensation	260	263
Research and Development Expense [Member]
Stock based compensation	423	339
General and Administrative Expense [Member]
Stock based compensation	$ 1,175	$ 1,944